Furthermore, the high IgM and IgG seroprevalence detected in the conducted study among smokers, participants aged ≥40 years, and patients with chronic diseases could reflect their more susceptibility to the SARS-CoV-2 infection and the special care needed for them to prevent COVID-19 complications. Here, CD40LG is linked to COVID-19.